drugset / Trial / NCT00239070

Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients

NCT00239070

Phase 3 Completed 69 enrolled Novartis
Non-randomizedSingle-groupOpen-labelPrevention

Summary

This extension study is to assess the long-term safety of EC-MPS

Timeline

Start
2003-04
Primary completion
2006-05
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Mycophenolate Sodium Unknown

Indications

No indication recorded.